Prescient Medicine Holdings, Inc.

Prescient Medicine is a privately held company focused on developing diagnostic tools that advance the precision healthcare movement. Prescient Medicine's mission is to accelerate the development, commercialization and deployment of advanced clinical diagnostics to address the most pressing public health issues in the U.S and around the world. Prescient Medicine builds powerful tests and analytic solutions to offer deep predictive insights so doctors and patients have the data they need to make better, more informed clinical decisions, and achieve the best possible patient outcomes. Prescient Medicine technologies include LifeKit® Predict, an in vitro diagnostic test commercialized in partnership with its subsidiary AutoGenomics, used for the identification of patients who may be at risk for opioid addiction and LifeKit® Prevent a diagnostic test designed to detect pre-cancerous polyps, as well as early-stage carcinomas. Prescient Medicine operates three CLIA-certified labs supporting ToxKit®, an advanced drug screening tool, and LifeKit®PreScript, an advanced pharmacogenomic test. Prescient has locations in California, Pennsylvania, Illinois and Kentucky.